Dr. Giselle Sholler, MD
Claim this profileHelen DeVos Children's Hospital
Studies Neuroblastoma
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Giselle Sholler, MD is currently running
Peptide Receptor Radionuclide Therapy
for Neuroblastoma
This trial is testing a new treatment called 67Cu-SARTATE for children with high-risk neuroblastoma. The treatment uses radiation to target and kill cancer cells. The goal is to see if this approach is safe and effective for these patients.
Recruiting1 award Phase 1 & 211 criteria
DFMO Maintenance Therapy
for Neuroblastoma
This trial tests a medication called DFMO in patients with high-risk neuroblastoma who are in remission. The goal is to prevent the cancer from returning by stopping an enzyme that cancer cells need to grow. DFMO was initially developed as a cancer therapeutic agent but gained renewed interest as a preventive agent after showing effectiveness in inhibiting cancer development in rodent models.
Recruiting1 award Phase 2
More about Giselle Sholler, MD
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Giselle Sholler, MD has experience with
- Difluoromethylornithine (DFMO)
- 64Cu-SARTATE
- 67Cu-SARTATE
Breakdown of trials Giselle Sholler, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Giselle Sholler, MD specialize in?
Giselle Sholler, MD focuses on Neuroblastoma and other conditions. In particular, much of their work with Neuroblastoma has involved treating patients, or patients who are undergoing treatment.
Is Giselle Sholler, MD currently recruiting for clinical trials?
Yes, Giselle Sholler, MD is currently recruiting for 2 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Giselle Sholler, MD has studied deeply?
Yes, Giselle Sholler, MD has studied treatments such as Difluoromethylornithine (DFMO), 64Cu-SARTATE, 67Cu-SARTATE.
What is the best way to schedule an appointment with Giselle Sholler, MD?
Apply for one of the trials that Giselle Sholler, MD is conducting.
What is the office address of Giselle Sholler, MD?
The office of Giselle Sholler, MD is located at: Helen DeVos Children's Hospital, Grand Rapids, Michigan 49503 United States. This is the address for their practice at the Helen DeVos Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.